Sickle Cell Disease

clinical topic updates by Julie Kanter, MD

Thrombotic risk in sickle cell disease (SCD) is not entirely understood; however, findings from clinical trials with antithrombotic agents provide ......READ MORE

Sickle Cell Disease

expert roundtables by Stella T. Chou, MD; Michael Rutledge DeBaun, MD, MPH; and Julie Kanter, MD

Established interventions for sickle cell disease (SCD), such as hydroxyurea and chronic transfusion therapy, have greatly improved outcomes. As no......READ MORE

Sickle Cell Disease

expert perspectives

Expert Perspectives delivers health care providers with insights from key thought leaders on the latest advancements and current practices in medic......READ MORE

Sickle Cell Disease

expert roundtables by Stella T. Chou, MD; Michael Rutledge DeBaun, MD, MPH; and Julie Kanter, MD

Some of the complications of sickle cell disease (SCD) that may be more likely to go unrecognized or underdiagnosed include depression, post-transf......READ MORE

Sickle Cell Disease

expert roundtables by Stella T. Chou, MD; Michael Rutledge DeBaun, MD, MPH; and Julie Kanter, MD

Hydroxyurea reduces the frequency of vaso-occlusive crisis (VOC), but some patients with sickle cell disease (SCD) still experience recurrent crise......READ MORE